Your browser doesn't support javascript.
loading
Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).
Novembre, Elio; Tosca, Mariangela; Caffarelli, Carlo; Calvani, Mauro; Cardinale, Fabio; Castagnoli, Riccardo; Chiappini, Elena; Cravidi, Claudio; Del Giudice, Michele Miraglia; Duse, Marzia; Licari, Amelia; Manti, Sara; Martelli, Alberto; Ricci, Giampaolo; Pingitore, Giuseppe; Marseglia, Gian Luigi.
Afiliación
  • Novembre E; Allergy Unit, Department of Pediatrics, Meyer Children's University Hospital, Florence, Italy.
  • Tosca M; Allergy Center, Istituto Giannina Gaslini, Genoa, Italy.
  • Caffarelli C; Pediatric Clinic, Department of Medicine and Surgery, University of Parma, Via Gramsci, 14, Parma, Italy. carlo.caffarelli@gmail.com.
  • Calvani M; Operative Unit of Pediatrics, S. Camillo-Forlanini Hospital, Rome, Italy.
  • Cardinale F; Pediatric Unit, Azienda Ospedaliero-Universitaria "Policlinico- Giovanni XXIII, Bari, Italy.
  • Castagnoli R; Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Chiappini E; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Cravidi C; Paediatric Infectious Diseases Unit, Department of Health Sciences, Anna Meyer Children's University Hospital, University of Florence, Florence, Italy.
  • Del Giudice MM; ATS Pavia, Pavia, Italy.
  • Duse M; Department of Woman and Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Licari A; Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, Italy.
  • Manti S; Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Martelli A; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Ricci G; Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Catania, Italy.
  • Pingitore G; Pediatrician at the University of Pavia, Pavia, Italy.
  • Marseglia GL; Alma Mater Studiorum, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Ital J Pediatr ; 48(1): 76, 2022 May 16.
Article en En | MEDLINE | ID: mdl-35578294
BNT162b2 vaccine, developed by BioNTech and Pfizer ha recently approved for use in children aged 5 to 11 years. Recent data show evidence of safety on the administration and serious adverse events have been rarely reported. However, allergic systemic reactions could occur. In some cases, a correct allergic evaluation allows identifying patients at risk of developing an anaphylactic reaction. Risk assessment of allergic reactions to COVID-19 vaccines is useful to limit contraindications to vaccination and help to safely vaccinate people supposed to be at risk of allergic reactions.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / COVID-19 / Anafilaxia Tipo de estudio: Guideline / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Ital J Pediatr Asunto de la revista: PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / COVID-19 / Anafilaxia Tipo de estudio: Guideline / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Ital J Pediatr Asunto de la revista: PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Italia